Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
| 255 | 3 | IMMUNOLOGY//CELLULAR IMMUNOLOGY//JOURNAL OF IMMUNOLOGY | 46035 |
| 1097 | 2 | INTERLEUKIN 2//OK 432//CANCER IMMUNOLOGY IMMUNOTHERAPY | 10078 |
| 820 | 1 | INTERLEUKIN 2//LYMPHOKINE ACTIVATED KILLER CELLS//TUMOR INFILTRATING LYMPHOCYTES | 3069 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | INTERLEUKIN 2 | authKW | 763561 | 17% | 15% | 512 |
| 2 | LYMPHOKINE ACTIVATED KILLER CELLS | authKW | 189371 | 2% | 27% | 69 |
| 3 | TUMOR INFILTRATING LYMPHOCYTES | authKW | 110702 | 3% | 12% | 93 |
| 4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 106850 | 7% | 5% | 215 |
| 5 | RECOMBINANT INTERLEUKIN 2 | authKW | 101831 | 1% | 40% | 25 |
| 6 | LAK CELLS | authKW | 92420 | 1% | 24% | 37 |
| 7 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | journal | 91725 | 2% | 14% | 66 |
| 8 | JOURNAL OF IMMUNOTHERAPY | journal | 83631 | 4% | 7% | 118 |
| 9 | ADOPTIVE IMMUNOTHERAPY | authKW | 53558 | 2% | 9% | 59 |
| 10 | RENAL CELL CARCINOMA | authKW | 51649 | 6% | 3% | 196 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 34506 | 55% | 0% | 1681 |
| 2 | Immunology | 12576 | 31% | 0% | 957 |
| 3 | Medicine, Research & Experimental | 3218 | 13% | 0% | 402 |
| 4 | Urology & Nephrology | 1017 | 6% | 0% | 184 |
| 5 | Hematology | 142 | 3% | 0% | 89 |
| 6 | Surgery | 116 | 6% | 0% | 174 |
| 7 | Cell Biology | 70 | 5% | 0% | 143 |
| 8 | Pharmacology & Pharmacy | 64 | 5% | 0% | 168 |
| 9 | Pathology | 38 | 2% | 0% | 52 |
| 10 | Medicine, General & Internal | 27 | 3% | 0% | 99 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | RUPPERT | 41070 | 0% | 100% | 4 |
| 2 | UNITE ONCOL RADIOTHER IE | 20535 | 0% | 100% | 2 |
| 3 | SECT MELANOMA RENAL CANC IMMUNOTHER Y | 15398 | 0% | 50% | 3 |
| 4 | UNITA IMMUNOTER IA CELLULARE | 13689 | 0% | 67% | 2 |
| 5 | 1 CHILDRENS PL ROOM 5725 | 10268 | 0% | 100% | 1 |
| 6 | ADDENBROOKES HOSP PATHOL IMMUNOL | 10268 | 0% | 100% | 1 |
| 7 | ADME TOXICOL SCREENING DEV S | 10268 | 0% | 100% | 1 |
| 8 | ADV BIOCHEMOTHER Y | 10268 | 0% | 100% | 1 |
| 9 | AFFILIATED HOSP 2 UROL | 10268 | 0% | 100% | 1 |
| 10 | ANTICANC DRUGS PHARMACOL TOXICOL | 10268 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 106850 | 7% | 5% | 215 |
| 2 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 91725 | 2% | 14% | 66 |
| 3 | JOURNAL OF IMMUNOTHERAPY | 83631 | 4% | 7% | 118 |
| 4 | BIOTHERAPY | 42720 | 1% | 12% | 35 |
| 5 | CANCER BIOTHERAPY | 38986 | 1% | 20% | 19 |
| 6 | MOLECULAR BIOTHERAPY | 22648 | 0% | 28% | 8 |
| 7 | CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 14611 | 1% | 3% | 46 |
| 8 | LYMPHOKINE AND CYTOKINE RESEARCH | 11155 | 1% | 7% | 16 |
| 9 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 7944 | 0% | 7% | 11 |
| 10 | CANCER RESEARCH | 7421 | 6% | 0% | 171 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |